Fingolimod is associated with a 0.5–0.6% of macular edema, usually presenting within the first 3–4 months; diagnosis usually requires optical coherence tomography and/or fluorescein angiography.

Figure 1: Characterization of the hybrid cell vaccine. The hybrid cell vaccination was well tolerated by all patients. There were no serious adverse effects or any clinical signs of autoimmune ...